Massachusetts General Hospital: Novel Treatment Using Patient's Own Cells Opens New Possibilities to Treat Parkinson's Disease
May 13, 2020
May 13, 2020
BOSTON, Massachusetts, May 13 -- Massachusetts General Hospital issued the following news release:
Reprogramming a patient's own skin cells to replace cells in the brain that are progressively lost during Parkinson's disease (PD) has been shown to be technically feasible, reports a team of investigators from McLean Hospital and Massachusetts General Hospital in the most recent issue of The New England Journal of Medicine.
PD is the second most common degenerat . . .
Reprogramming a patient's own skin cells to replace cells in the brain that are progressively lost during Parkinson's disease (PD) has been shown to be technically feasible, reports a team of investigators from McLean Hospital and Massachusetts General Hospital in the most recent issue of The New England Journal of Medicine.
PD is the second most common degenerat . . .